期刊文献+

临床可触及巨大病灶的乳腺导管原位癌诊疗体会及文献复习

下载PDF
导出
摘要 对2例乳腺导管原位癌病例的体征、手术方法、病理及免疫组化结果,内分泌治疗予以总结分析,并结合相关文献复习乳腺导管原位癌的相关知识。
出处 《现代肿瘤医学》 CAS 2007年第11期1612-1613,共2页 Journal of Modern Oncology
  • 相关文献

参考文献13

  • 1Page DL, Dupont WD, Rogers LW, et al. Continued local recurrence of carcinoma 15-25 years after a diagnosis of low grade duetal carcinoma in site of the breast treated only by biopsy [J]. Cancer, 1995,76(7) :1197-1200.
  • 2Tavassoli FA, Devilee P. WHO classification of tumors pathology &genetics, tumors of the breast and femal egenital organs [M]. Lyon:IARC Press,2003.10.
  • 3Silverstein MJ, Waisman JR, Gamagami P, et al. Intraductal carcinoma of the breast ( 208 cases) : clinical factors influencing treatment choice[J]. Cancer, 1990,66 : 102-108.
  • 4Lagios MD. Ductal Carcinoma in situ:pathology and treatment[ J ]. Surg Clin North Am, 1990,70:853.
  • 5Cornfield DB, Palazzo JP,Sehwartz CF,et al. The prognostic significance of multiple morphologic features and biologic markers inductal carcinoma insitu of the breast: a study of a large cohort of patients treated with surgery alone[J]. Cancer,2004, 100:2317-2327.
  • 6Fisher B, Anderson S, Bryant J, et al. Twenty year follow up of a randiomized trial comparing to total mastectomy, lumpectomy and lumpectomy and lumpectomy plus irradiation for the treatment invasive breast cancer [J]. N Eng J Med,2002,347 (16): 1233 - 1241.
  • 7Amichetti M,Caffo O, Richetti A,et al. Ten year results of treatment of ductal carcinoma in situ (DCIS) of the breast with conservative surgery and radiotherapy [J]. Eur J Cancer, 1997,33 (10): 1559-1565.
  • 8Bordeleau L, Rakovitch E, Naimark DM, et al. A comparison of four treatments trategies for ductal carcinoma in situ using decision analysis [J]. Cancer, 2001,92(1) :23 - 29.
  • 9Chan KC, Knox WF, Sinha G, et al. Extent of excision margin width required in breast conserving surgery for ductal cacinoma in situ [J]. Cancer,2001,91(1):916.
  • 10左文述,路平华.乳腺导管内癌及小叶原位癌的治疗策略[J].中国肿瘤临床,2002,29(5):376-380. 被引量:7

二级参考文献37

  • 1[1]Sakorafas GH, Tsiotou AG. Ductal carcinoma in situ (DCIS)of the breast: evolving perspectives. Cancer Treat Rev, 2000,26(2): 103~125
  • 2[2]Fisher ER, Dignam J, Tan-Chiu-E, et al. Pathologic tindings from the National Surgical Adjuvant Breast Project (NSABP)eight-year update of Protocol B-17: intraductal carcinoma.Cancer, 1999, 86(3): 429~438
  • 3[3]Leal CB, Schmitt FC, Bento MJ, et al. Ductal carcinoma in situ of the breast. Histologic categorization and its relationship to ploidy and immunohistochemical expression of hormone re ceptors, p53, and c-erbB-2 protein. Cancer, 1995, 75(8):2123 ~2131
  • 4[4]Sloane JP, Amendoeira I, Apostolikas N, et al. Consistency achieved by 23 European pathologists in categorizing ductal carcinoma in situ of the breast using five classifications. Euro pean Commission Working Group on Breast Screening Pathology. Hum Pathol, 1998, 29(10): 1056~1062
  • 5[5]Warnberg F, Nordgren H, Bergh J, et al. Ductal carcinoma in situ of the breast from a population-defined cohort: an evalu ation of new histopathological classification systems. Eur J Cancer, 1999, 35(5): 714~720
  • 6[6]Holland R, Peterse JL, Millis RR, et al. Ductal carcinoma in situ: a proposal for a new classification. Semin Diagn Pathol,1994, 11(3): 167~180
  • 7[7]Wells WA, Carney PA, Eliassen MS, et al. Pathologists' a greement with experts and reproducibility of breast ductal car cinoma~in~situ classification schemes. Am J Surg Pathol,2000, 24(5): 651~659
  • 8[8]Kanthan R, Xiang J, Magliocco AM. p53, ErbB2, and TAG 72 expression in the specrum of ductal carcinoma in situ of the breast classified by the Van Nuys system. Arch Pathol Lab Med, 2000, 124(2): 234~239
  • 9[9]Poller DN. Pathology of ductal carcinoma in situ of the breast: current status. EurJ Surg Oncol, 2001, 27(5): 498~503
  • 10[10]Silverstein MJ, Poller DN, Waisman JR, et al. Prognostic clas sification of breast ductal carcinoma-in-situ. Lancet, 1995, 345(8958): 1154~1157

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部